Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06395506
NA

THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation

Sponsor: The University of Texas Medical Branch, Galveston

View on ClinicalTrials.gov

Summary

The study's purpose is to evaluate whether creatine supplementation can help breast cancer survivors respond quicker to exercise by improving strength, endurance, and body composition. We are seeking to compare information collected from healthy woman of the same age who have never had breast cancer to those participants who have had breast cancer and undergone chemotherapy treatment.

Official title: An Open-label Randomized Trial of Exercise ± Creatine Supplementation to Augment the Adaptations of Exercise Training in Cancer Survivors

Key Details

Gender

FEMALE

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-10-29

Completion Date

2028-05-31

Last Updated

2025-12-24

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Creatine

Those randomized to receive creatine (experimental group) will be initially dosed at 20 g/day for 7 days to boost availability of creatine systemically. Thereafter, the dose will be reduced to 5 g/day for maintenance through the duration of the 12-week protocol.

Locations (1)

The University of Texas Medical Branch, Galveston

Galveston, Texas, United States